Acute phase hyperglycemia among patients hospitalized with acute coronary syndrome: Prevalence and prognostic significance

Oman Medical Journal

Volumn 26, Issue 2, 2011, Pages 85-90

  Mansour, Abbas Ali ^a   Wanoose, Hameed Laftah ^b  

^a UNIVERSITY OF BASRAH   (Iraq)

^b Al Faiha Hospital Basrah   (Iraq)

Author keywords

Acute coronary syndrome; Diabetes; Plasma glucose; Stress hyperglycemia

Indexed keywords

EID: 84858264918     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: 10.5001/omj.2011.22     Document Type: Article

References (33)

1. Norhammar AM, Rydén L, Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999 Nov;22(11):1827-1831.
2. Foo K, Cooper J, Deaner A, Knight C, Suliman A, Ranjadayalan K, et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 2003 May;89(5):512-516.
3. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL; ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002 Nov;40(10):1748-1754.
4. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000 Aug;321(7258):405-412.
5. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000 Mar;355(9206):773-778.
6. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed) 1986 Oct;293(6552):917-922.
7. Lynch M, Gammage MD, Lamb P, Nattrass M, Pentecost BL. Acute myocardial infarction in diabetic patients in the thrombolytic era. Diabet Med 1994 Mar;11(2):162-165.
8. Ravid M, Berkowicz M, Sohar E. Hyperglycemia during acute myocardial infarction. A six-year follow-up study. JAMA 1975 Aug;233(7):807-809.
9. Bellodi G, Manicardi V, Malavasi V, Veneri L, Bernini G, Bossini P, et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989 Oct;64(14):885-888.
10. Soler NG, Frank S. Value of glycosylated hemoglobin measurements after acute myocardial infarction. JAMA 1981 Oct;246(15):1690-1693.
11. O'Sullivan JJ, Conroy RM, Robinson K, Hickey N, Mulcahy R. In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 1991 Aug;14(8):758-760.
12. Sewdarsen M, Vythilingum S, Jialal I, Becker PJ. Prognostic importance of admission plasma glucose in diabetic and non-diabetic patients with acute myocardial infarction. Q J Med 1989 May;71(265):461-466.
13. Gwilt DJ, Petri M, Lamb P, Nattrass M, Pentecost BL. Effect of intravenous insulin infusion on mortality among diabetic patients after myocardial infarction. Br Heart J 1984 Jun;51(6):626-630.
14. Ceriello A. Acute hyperglycaemia: a 'new' risk factor during myocardial infarction. Eur Heart J 2005 Feb;26(4):328-331.
15. Weihrauch D, Lohr NL, Mraovic B, Ludwig LM, Chilian WM, Pagel PS, et al. Chronic hyperglycemia attenuates coronary collateral development and impairs proliferative properties of myocardial interstitial fluid by production of angiostatin. Circulation 2004 May;109(19):2343-2348.
16. Nielson C, Lange T. Blood glucose and heart failure in nondiabetic patients. Diabetes Care 2005 Mar;28(3):607-611.
17. Nielson C, Lange T, Hadjokas N. Blood glucose and coronary artery disease in nondiabetic patients. Diabetes Care 2006 May;29(5):998-1001.
18. Hadjadj S, Coisne D, Mauco G, Ragot S, Duengler F, Sosner P, et al. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med 2004 Apr;21(4):305-310.
19. Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 2004 May;164(9):982-988.
20. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000 Sep;21(18):1502-1513.
21. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). ACC/ AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004 Aug;110(5):588-636.
22. Hamm CW, Bertrand M, Braunwald E. Acute coronary syndrome without ST elevation: implementation of new guidelines. Lancet 2001 Nov;358(9292):1533-1538.
23. Morrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, Lakkis N, et al; TACTICS-TIMI 18 Investigators. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 2001 Nov;286(19):2405-2412.
24. Timmer JR, Bilo HJ, Ottervanger JP, Dambrink JH, Miedema K, Hoorntje JC, et al. Dysglycemia in suspected acute coronary syndromes. Eur J Intern Med 2005 Feb;16(1):29-33.
25. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ 1997 May;314(7090):1303-1306.
26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 Jun;18(6):499-502.
27. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996 Oct;335(18):1342-1349.
28. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005 Jun;111(23):3078-3086.
29. Kosiborod M. Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction. Diab Vasc Dis Res 2008 Nov;5(4):269-275.
30. Inzucchi SE. Hyperglycaemia and its therapy during acute coronary syndromes. Diab Vasc Dis Res 2008 Nov;5(4):259.
31. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, et al. Fasting glucose is an important independent risk factor for 30- day mortality in patients with acute myocardial infarction: a prospective study. Circulation 2005 Feb;111(6):754-760.
32. Gasior M, Pres D, Stasik-Pres G, Lech P, Gierlotka M, Hawranek M, et al. Effect of blood glucose levels on prognosis in acute myocardial infarction in patients with and without diabetes, undergoing percutaneous coronary intervention. Cardiol J 2008;15(5):422-430.
33. Karlsberg RP, Cryer PE, Roberts R. Serial plasma catecholamine response early in the course of clinical acute myocardial infarction:relation to infarct extent and mortality. Am Heart J. 1981 Jul; 102(1):24-9.